Abstract
The aim of this study was to explore whether bone marrow mononuclear cell (BMMC) transplantation is able to accelerate the bone remodeling induced by midpalatal expansion in rats. A total of 48 male Sprague-Dawley rats (mean weight, 208.36±7.32 g) were divided into control and midpalatal expansion with or without BMMC transplantation groups. Histological and morphological changes were observed in each group. The osteogenic activities and differential potentials of the transplanted BMMCs labeled with bromodeoxyuridine in the midpalatal bone tissue were assessed by osteocalcin expression. The receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) ratio was determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to reflect the equilibrium between bone resorption and formation. The results demonstrated that the width of the maxillary dental arch increased distinctly within 2 weeks of midpalatal expansion with BMMC transplantation. The morphology of the midpalatal suture in this group changed significantly; the cartilage was completely replaced by fibrous-like tissue expressing osteocalcin. The palatal bone was reorganized from a cancellous form into a mature compact structure after an additional 2-week relapse period. Immunostaining results indicated that the heterologous transplanted BMMCs survived and differentiated into osteoblasts during the remodeling induced by midpalatal expansion. The RANKL/OPG expression ratio significantly decreased after 2 weeks of midpalatal expansion with BMMC transplantation due to the inhibition of RANKL expression. Heterologous BMMC transplantation appears to accelerate the midpalatal bone remodeling induced by expansion of the rats through increasing the number of osteoprogenitor cells and regulating the RANKL-OPG signaling pathway.
Highlights
Rapid midpalatal expansion (RME) is a common treatment for patients with a narrow maxillary dental arch
The remaining rats were divided into five groups (n=9 per group): Non‐expansion control group (NC), in which the midpalatal suture of the rats was cut; expansion group (Exp), in which the rats underwent midpalatal expansion for 2 weeks; expansion and transplantation group (EaT), in which rats underwent midpalatal expansion for 2 weeks with midpalatal incision and bone marrow mononuclear cell (BMMC) transplantation: expansion and relapse group (ExR); and expansion, transplantation and relapse group (EtR)
Orthodontists often use midpalatal expansion to treat malocclusion caused by a narrow maxillary dental arch
Summary
Rapid midpalatal expansion (RME) is a common treatment for patients with a narrow maxillary dental arch. It has been effectively used to correct transverse maxillary discrepancies in children and adolescents up to the pubertal stage [1]. The maxillary dental arch increases rapidly with active tissue remodeling in the palate [2]. Surgical assistance, such as measured tipping of the anchor teeth, is often used to eliminate side‐effects [3]. Certain clinicians use expansion treatments to treat adult patients who have a narrow maxillary arch with increasing skeletal resistance [6,7]. The effectiveness of this treatment has been reported, the long‐term dental and skeletal stability remains uncertain [8]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
